Assessment of brain natriuretic peptide in patients with suspected heart failure: comparison with radionuclide ventriculography data (Q30643776)

25 June 2017

title

Assessment of brain natriuretic peptide in patients with suspected heart failure: comparison with radionuclide ventriculography data (English)

1 reference

brain natriuretic peptide

25 June 2017

main subject

0 references

radionuclide ventriculography

1 reference

Valli N

1

1 reference

25 June 2017

Georges A

2

1 reference

25 June 2017

Corcuff JB

3

1 reference

25 June 2017

Barat JL

4

1 reference

25 June 2017

Bordenave L

5

1 reference

25 June 2017

publication date

1 April 2001

1 reference

25 June 2017

1 reference

25 June 2017

volume

306

1 reference

25 June 2017

issue

1-2

1 reference

25 June 2017

page(s)

19-26

1 reference

A new natriuretic peptide in porcine brain

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Validating aminoterminal BNP assays: a word of caution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Brain natriuretic peptide in an elderly population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Review of 10 years of the clinical use of brain natriuretic peptide in cardiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Medical advances in the treatment of congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

The prevention of heart failure--a new agenda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Validity of clinical diagnosis of heart failure in primary health care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Atrial peptides, ANP(1-98) and ANP(99-126) in health and disease in an elderly population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Plasma brain natriuretic peptide as a biochemical marker for atrioventricular sequence in patients with pacemakers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Natriuretic peptides and cyclic guanosine 3',5'-monophosphate in asymptomatic and symptomatic left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Brain natriuretic peptide is a sensitive indicator of impaired left-ventricular function in elderly patients with cardiovascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Biochemical detection of left-ventricular systolic dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Plasma concentrations of brain natriuretic peptide: will this new test reduce the need for cardiac investigations?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Asymptomatic left ventricular dysfunction in the community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Clinical criteria and biochemical markers for the detection of systolic dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

BNP: soon to become a routine measure in the care of patients with heart failure?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: cross-sectional study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Evaluation of brain natriuretic peptide in the diagnosis of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Can heart failure be diagnosed in primary care?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Failure of plasma brain natriuretic peptide to identify left ventricular systolic dysfunction in the community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Brain and atrial natriuretic peptides in patients with ischemic heart disease with and without heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Natriuretic peptide system in human heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900388-6

10.1016/S0009-8981(01)00388-6

7 January 2021

Identifiers

DOI

1 reference

25 June 2017

1 reference